IntelGenx Technologies Corp. (CVE:IGX – Get Free Report) shot up 1.8% on Monday . The stock traded as high as C$0.60 and last traded at C$0.58. 11,848 shares were traded during mid-day trading, a decline of 79% from the average session volume of 56,279 shares. The stock had previously closed at C$0.57.
IntelGenx Technologies Price Performance
The company has a quick ratio of 2.69, a current ratio of 2.77 and a debt-to-equity ratio of 164.62. The stock has a market capitalization of C$87.32 million and a PE ratio of -7.44. The company has a 50-day moving average of C$0.58 and a 200 day moving average of C$0.58.
IntelGenx Technologies Company Profile
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.
See Also
- Five stocks we like better than IntelGenx Technologies
- Earnings Per Share Calculator: How to Calculate EPS
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- What is the Shanghai Stock Exchange Composite Index?
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
